Analysis of the severity of dyskinesia in Patients with Parkinson's disease via wearable sensors

Proceedings - BSN 2006: International Workshop on Wearable and Implantable Body Sensor Networks

Volumn 2006, Issue , 2006, Pages 123-126

  Patel, Shyamal ^a   Sherrill, Delsey ^a   Hughes, Richard ^a   Hester, Todd ^a   Huggins, Nancy ^b   Lie Nemeth, Theresa ^a   Standaert, David ^b   Bonato, Paolo ^a,c  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Clustering; Dyskinesia; Parkinson's disease; Wearable sensors

Indexed keywords

CLUSTERING ANALYSIS; DYSKINESIA; PARKINSON'S DISEASE; WEARABLE SENSORS;

BIOLOGICAL ORGANS; BIOSENSORS; DATA ACQUISITION; MOTORS; OPTIMIZATION; PATIENT MONITORING;

DISEASES;

EID: 33750807885     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BSN.2006.10     Document Type: Conference Paper

References (12)

1. DG Standaert, AB Young, in Goodman and Gilman's Pharmacological Basis of Therapeutics, Tenth Edition, Hardman JG and Limbird LE, Editors, McGraw-Hill, 549-620, 2001.
2. TN Chase, "Levodopa therapy: consequences of the non physiologic replacement of dopamine", Neurology, 50(Suppl5): S17-S25, 1998.
3. JA Obeso, CW Olanow, JG Nutt, "Levodopa motor complications in Parkinson's disease", Trends Neurosci, 23: 2-7, 2000.
4. S Fahn, RL Elton, "Unified Parkinson's Disease Rating Scale". In Fahn S (Ed), Recent Developments in Parkinson's Disease, MacMillan Healthcare Information, 153-163, 1987.
5. AE Lang, AM Lozano, "Parkinson's disease. First of two parts", N Engl J Med, 339(16): 1044-1053, 1998.
6. AE Lang, AM Lozano, "Parkinson's disease. Second of two parts", N Engl J Med, 339(16): 1130-1143, 1998.
7. PJ Blanchet, SM Papa, LV Metman, MM Mouradian, TN Chase, "Modulation of levodopainduced motor response complications by NMDA antagonists in Parkinson's disease", Neurosci Biobehav Rev, 21: 447-453, 1997.
8. MM Mouradian, IJ Heuser, F Baronti, TN Chase, "Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease", Ann Neurol, 27(1): 18-23, 1990.
9. IT Jolliffe, Principal Components Analysis. New York: Springer-Verlag, 1986.
10. MP Sammon, EN Bruce, "Vagal afferent activity increases dynamical dimension of respiration in rats", J Appl Physiol, 70(4): 1748-1762, 1991.
11. nd edition, Wiley Interscience, 2001.
12. JC Bezdek, NR Pal "Some new indexes of cluster validity", IEEE Transactions on System, Man, and Cybernetics-part B: Cybernetics, Vol. 28, No. 3, June 1998.